25/01/2024  16:25:52 Chg. - Volume Bid- Demandez à- Capitalisation boursière Dividende Y. Rapport P/E
51.6000USD - 912
Chiffrre d'affaires: 47,059.2000
-Bid taille: - -Ask la taille: - 11.28 Mrd.USD - -

Description de l'entreprise

Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange, with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties within the urogenital therapeutic area and of treatments for rare diseases.
 

Conseil d'administration & Conseil de surveillance

PDG
Robert Koremans
Conseil d'administration
Andrea Recordati, Giampiero Mazza, Guido Guidi, Joanna Le Couilliard, Michaela Castelli, Piergiorgio Peluso, Cathrin Petty, Giorgio De Palma, Elisa Corghi, Luigi La Corte, Kim Stratton
Conseil de surveillance
Antonio Santi, Andrea Balelli, Ezio Simonelli, Livia Amidani Aliberti, Patrizia Oriundi Paleologo, Emiliano Nitti , Marco Antonio Viganò
 

Données de l'entreprise

Nom: Recordati S.p.A.
Adresse: via M. Civitali 1,I-20148 Milano
Téléphone: +39-02-48787-1
Fax: +39-02-40073-747
Courriel: -
Internet: www.recordati.com/
Industrie: Healthcare
Secteur: Pharmaceutical Industry
Sous-secteur: Pharmaceuticals
Fin de l'exercice financier: 31/12
Flotte libre: 46.40%
IPO date: 01/01/1984

Relations avec les investisseurs

Nom: Marianne Tatschke
Téléphone IR: -
IR-Fax: +39-02-48787-225
E-mail IR: inver@recordati.it

Calendrier de l'entreprise

CW 21 | 20/05/2024 Ex-Dividend
CW 21 | 21/05/2024 Record Date
CW 21 | 22/05/2024 Dividend Payment
CW 31 | 30/07/2024 Interim Report 2nd Quarter/6 Months
CW 45 | 08/11/2024 Interim Report 3rd Quarter/9 Months
 

Principaux actionnaires

CVC Capital Partners
 
51.80%
Autres
 
48.20%